Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The MELILLA HEALTH CARE MANAGEMENT - NATIONAL INSTITUTE OF HEALTH MANAGEMENT has issued a Tender notice for the procurement of a Supply of Active Ingredient Medications: Interferon Beta 1-A, Cannabinol-Ronabinol and Avelumab, Dispensed at the University Hospital Dependent on Ingesa for Patients of the Management Of... in the Spain. This Tender notice was published on 02 Jun 2026 and is scheduled to close on 01 Jul 2026, with an estimated Tender value of EUR 149091.29. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 142469404, while the tender notice number is 378009-2026 and Registering on the platform.
Procurement Summary
Country: Spain
Summary: Supply of Active Ingredient Medications: Interferon Beta 1-A, Cannabinol-Ronabinol and Avelumab, Dispensed at the University Hospital Dependent on Ingesa for Patients of the Management Of...
Deadline: 01 Jul 2026
Posting Date: 02 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 142469404
Document Ref. No.: 378009-2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: EUR 149091.29
CPV Classification
33600000 - Pharmaceutical productsPurchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Supply of active ingredient medications: INTERFERON BETA 1-A, CANNABINOL-RONABINOL AND AVELUMAB, dispensed at the University Hospital dependent on INGESA for patients of the Management of... Interferon BETA 1-A Medication Medication Cannabino-Dronabinol Avelumab medication Supply of active ingredient medications: INTERFERON BETA 1-A, CANNABINOL-RONABINOL AND AVELUMAB, dispensed at the University Hospital dependent on INGESA for patients of the Care Management Melilla Sanitary. MEDICATION INTERFERON BETA 1-A Cannabino-Dronabinol Medication Avelumab medication Doc Title: Supply of active ingredient medications: INTERFERON BETA 1-A, CANNABINOL-RONABINOL AND AVELUMAB, dispensed at the University Hospital dependent on INGESA for patients of the Melilla Health Care Management. Contract Type: supplies
Document Type: Contract Notice Reference Number: P.A. 2026-046-GME Contract Type: supplies Estimated Value: 149091.29 - EUR Authority Type: cga Doc Title: Suministro de medicamentos principios activos: INTERFERON BETA 1-A, CANNABINOL-RONABINOL Y AVELUMAB, dispensed at the University Hospital dependent on INGESA for patients of the Melilla Health Care Management. Dispatch Date: 2026-06-01 Publish Date: 2026-06-02 Submission Date: 2026-07-01
Documents
Similar Tenders
Spain
149707607
08 Oct 2026
EUR 158138.62
Spain
149707606
08 Oct 2026
EUR 56500.00
Spain
149707506
16 Oct 2026
EUR 192632.00
Spain
149707477
13 Oct 2026
EUR 115702.48
Spain
149707472
26 Oct 2026
EUR 1621766.00
Procurement Documents for Spain
Access a comprehensive library of standard procurement documents specific to Spain. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Spain
Want To Bid in This Tender?
Get Local Agent Support in Spain and 60 More Countries.
View Tenders By
Sign in with Google